Biomarkers: the next therapeutic hurdle in metastatic renal cell carcinoma

Yazar: Sonpavde, G, Choueiri, T K
Baskı/Yayın Bilgisi 2012

Updates on novel therapies for metastatic renal cell carcinoma

Yazar: Courtney, Kevin D., Choueiri, Toni K.
Baskı/Yayın Bilgisi 2010

STATIN USE AND THE RISK OF RENAL CELL CARCINOMA IN 2 PROSPECTIVE US COHORTS

Yazar: Liu, Wei, Choueiri, Toni K., Cho, Eunyoung
Baskı/Yayın Bilgisi 2011

Analgesic use and the risk of kidney cancer: a meta-analysis of epidemiologic studies

Yazar: Choueiri, Toni K., Je, Youjin, Cho, Eunyoung
Baskı/Yayın Bilgisi 2013

Cardiovascular Complications Associated with Novel Angiogenesis Inhibitors: Emerging Evidence and Evolving Perspectives

Yazar: Bair, Steven M., Choueiri, Toni K., Moslehi, Javid
Baskı/Yayın Bilgisi 2013

ABO blood group and risk of renal cell cancer

Yazar: Joh, Hee-Kyung, Cho, Eunyoung, Choueiri, Toni K.
Baskı/Yayın Bilgisi 2012

PD-1 Blockade in Renal Cell Carcinoma: To Equilibrium and Beyond

Yazar: Harshman, Lauren C., Drake, Charles G., Choueiri, Toni K.
Yayımlandı Cancer Immunol Res (2014)

Impact of Body Composition on Clinical Outcomes in Metastatic Renal Cell Cancer

Yazar: Tang, Patricia A., Heng, Daniel Y. C., Choueiri, Toni K.
Baskı/Yayın Bilgisi 2011

Rationale for and Review of Neoadjuvant Therapy Prior to Radical Prostatectomy for Patients with High-Risk Prostate Cancer

Yazar: McKay, Rana R., Choueiri, Toni K., Taplin, Mary-Ellen
Baskı/Yayın Bilgisi 2013

Optimizing bone health and minimizing skeletal morbidity in men with prostate cancer

Yazar: McKay, Rana R., Taplin, Mary-Ellen, Choueiri, Toni K.
Baskı/Yayın Bilgisi 2013

Optimizing systemic therapy for metastatic renal cell carcinoma beyond the first-line setting

Yazar: de Velasco, Guillermo, Hamieh, Lana, Mickey, Suzanne, Choueiri, Toni K.
Yayımlandı Urol Oncol (2015)

RECIST 1.1 Compared With RECIST 1.0 in Patients With Advanced Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor–Targeted Therapy

Yazar: Krajewski, Katherine M., Nishino, Mizuki, Ramaiya, Nikhil H., Choueiri, Toni K.
Yayımlandı AJR Am J Roentgenol (2015)

QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitors

Yazar: Ghatalia, P, Je, Y, Kaymakcalan, M D, Sonpavde, G, Choueiri, T K
Yayımlandı Br J Cancer (2015)

Subverting the B7-H1/PD-1 Pathway in Advanced Melanoma and Kidney Cancer

Yazar: Harshman, Lauren C., Choueiri, Toni K., Drake, Charles, Hodi, F. Stephen
Yayımlandı Cancer J (2014)

Treatment Selection for Patients With Metastatic Renal Cell Carcinoma

Yazar: Atkins, Michael B., Choueiri, Toni K., Cho, Daniel, Regan, Meredith, Signoretti, Sabina
Baskı/Yayın Bilgisi 2009

Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma

Yazar: Motzer, Robert J., Escudier, Bernard, Powles, Thomas, Scheffold, Christian, Choueiri, Toni K.
Yayımlandı Br J Cancer (2018)

Activation of c-Met in cancer cells mediates growth-promoting signals against oxidative stress through Nrf2-HO-1

Yazar: Chakraborty, Samik, Balan, Murugabaskar, Flynn, Evelyn, Zurakowski, David, Choueiri, Toni K., Pal, Soumitro
Yayımlandı Oncogenesis (2019)

Systemic Therapy for Metastatic Non-Clear Cell Renal Cell Carcinoma: Recent Progress and Future Directions

Yazar: Chowdhury, Simon, Matrana, Marc, Tsang, Christopher, Atkinson, Bradley, Choueiri, Toni K., Tannir, Nizar M.
Baskı/Yayın Bilgisi 2011

Impact of Geographic Regions on Overall Survival in Patients With Metastatic Renal Cell Carcinoma: Results From an International Clinical Trials Database

Yazar: Fay, Andre P., McKay, Rana R., Lin, Xun, Simantov, Ronit, Choueiri, Toni K.
Yayımlandı J Glob Oncol (2018)

Carbonic anhydrase IX as a potential biomarker of efficacy in metastatic clear-cell renal cell carcinoma patients receiving sorafenib or placebo: Analysis from the treatment approa...

Yazar: Choueiri, Toni K., Cheng, Suchun, Qu, Angela Q., Pastorek, Jaromir, Atkins, Michael B., Signoretti, Sabina
Yayımlandı Urol Oncol (2012)